Skip to main content
OpenTrials

Clinical trial condition

HER2-positive Breast Cancer

Explore clinical trials studying HER2-positive Breast Cancer. Study availability and eligibility vary by location and protocol.

202 public trials 83 recruiting studies
Refine in advanced search Browse all conditions

HER2-positive Breast Cancer trial results

Recruiting

ATEMPT 2.0: Adjuvant T-DM1 vs TH

NCT04893109

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Smilow Cancer Hospital Care center at Derby Derby, Connecticut, United States
  • Smilow Cancer Hospital Care center at Fairfield Fairfield, Connecticut, United States
  • Smilow Cancer Hospital Care center at Glastonbury Glastonbury, Connecticut, United States
View all 53 locations
View Trial Details
Recruiting

PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer

NCT04360941

Conditions
Breast Diseases, Breast Neoplasms, ER+ Breast Cancer, +10 more
Locations
  • The Christie NHS Foundation Trust Manchester, Greater Manchester, United Kingdom
  • Addenbrooke's Hospital Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom
  • Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
  • Hope Clinical Trials Cancer Centre Leicester, United Kingdom
View Trial Details
Recruiting

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

NCT07102381

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Oncology Institute Long Beach, California, United States
  • Cancer & Blood Research Center Los Alamitos, California, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Holy Cross Hospital Fort Lauderdale, Florida, United States
View all 33 locations
View Trial Details
Recruiting

RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive

NCT07413939

Conditions
HER2-positive Breast Cancer
Locations
  • Hospital Provincial del Centenario Rosario, Argentina
  • Monash Health Clayton, Victoria, Australia
  • Barwon Health Geelong, Victoria, Australia
  • Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
View all 109 locations
View Trial Details
Recruiting

A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer

NCT07673029

Conditions
HER2-positive Breast Cancer
Locations
  • The First Affiliated Hospital of Bengbu Medical University Bengbu, Anhui, China
  • The Affiliated Fuyang Hospital of Anhui Medical University Fuyang, Anhui, China
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Anhui Cancer Hospital Hefei, Anhui, China
View all 70 locations
View Trial Details
Recruiting

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

NCT04585750

Conditions
Adnexal Diseases, Advanced Malignant Neoplasm, Advanced Solid Tumor, +81 more
Locations
  • University of California Irvine Chao Family Comprehensive Cancer Center Irvine, California, United States
  • University of San Diego Moores Cancer Center La Jolla, California, United States
  • UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 77 locations
View Trial Details

Related conditions